Corever in the Treatment of Hypertension

NCT02432937 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Corever

Sponsor

TSH Biopharm Corporation Limited